These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3360275)

  • 41. Nontransferrin-bound serum iron in thalassemia and sickle cell patients.
    Ahmed NK; Hanna M; Wang W
    Int J Biochem; 1986; 18(10):953-6. PubMed ID: 3792614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of sickle cell beta o-thalassemia and sickle cell beta +-thalassemia in black populations.
    Serjeant GR; Serjeant BE
    Birth Defects Orig Artic Ser; 1982; 18(7):223-9. PubMed ID: 7159733
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical management of beta-thalassemia.
    Lerner N
    Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
    [No Abstract]   [Full Text] [Related]  

  • 45. Toxicity of oral iron chelator L1.
    Bichile SK; Mehta PJ; Parekh SJ
    J Assoc Physicians India; 1993 Jun; 41(6):323-4. PubMed ID: 8005960
    [No Abstract]   [Full Text] [Related]  

  • 46. Iron metabolism in thalassemia intermedia.
    Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
    Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia.
    Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C
    Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-transfusional iron overload in the haemoglobinopathies.
    Thuret I
    C R Biol; 2013 Mar; 336(3):164-72. PubMed ID: 23643400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
    Constantoulakis M; Economidou J; Karagiorga M; Katsantoni A; Gyftaki E
    Ann N Y Acad Sci; 1974; 232(0):193-200. PubMed ID: 4528481
    [No Abstract]   [Full Text] [Related]  

  • 50. Erythrocyte ferritin in thalassemia syndromes.
    Piperno A; Taddei MT; Sampietro M; Fargion S; Arosio P; Fiorelli G
    Acta Haematol; 1984; 71(4):251-6. PubMed ID: 6426238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Iron deficiency anaemia].
    Leporrier M; Seguin A
    Rev Prat; 2004 Jan; 54(2):217-23. PubMed ID: 15086065
    [No Abstract]   [Full Text] [Related]  

  • 52. Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes.
    Murray N; Serjeant BE; Serjeant GR
    Br J Haematol; 1988 May; 69(1):89-92. PubMed ID: 2454649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.
    Fasano RM; Branscomb J; Lane PA; Josephson CD; Snyder AB; Eckman JR
    Transfus Med; 2019 Jun; 29(3):185-192. PubMed ID: 30740798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

  • 55. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
    Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G;
    Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The measurement of free erythrocyte porphyrin (FEP) as a simple means of distinguishing iron deficiency from beta-thalassemia trait in subjects with microcytosis.
    Stockman JA; Weiner LS; Simon GE; Stuart MJ; Oski FA
    J Lab Clin Med; 1975 Jan; 85(1):113-9. PubMed ID: 1141725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of Mossbauer spectroscopy to the study of hemoglobinopathies. Preliminary experience].
    Abreu MS; Sanchís ME; Peñalver JA; Kanter F
    Sangre (Barc); 1989 Oct; 34(5):325-8. PubMed ID: 2617381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iron status and anemia in thalassemic Sardinian carriers.
    Pardini S; Dore F; Oggiano L; Bonfigli S; Pacifico S; Campus S; Longinotti M
    Haematologica; 1986; 71(1):17-9. PubMed ID: 3084350
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of blood transfusions on the indices of immunity and iron metabolism in patients with different forms of thalassemia].
    Ragimov AA; Dashkova NG; Nazarli AG; Zeĭnalova AA; Efendieva EG
    Gematol Transfuziol; 1986 Nov; 31(11):14-8. PubMed ID: 3803886
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of indirect and direct measurement of transferrin in healthy and sick children (author's transl)].
    Bender-Götze C; von Pilar CE; Fischer N
    Monatsschr Kinderheilkd; 1980 Sep; 128(9):598-601. PubMed ID: 6107844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.